US Stock MarketDetailed Quotes

LYEL Lyell Immunopharma

Watchlist
  • 1.170
  • -0.010-0.85%
Close Oct 18 16:00 ET
  • 1.170
  • 0.0000.00%
Post 16:59 ET
299.52MMarket Cap-1409P/E (TTM)

Lyell Immunopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Lyell Immunopharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
--2024/Q213.000K / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q413.000K / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
--2024/Q213.000K / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q413.000K / 0.000--

Unlock Free Earnings Estimates

Lyell Immunopharma Earnings Reports

  • Lyell Immunopharma | 10-Q: Q2 2024 Earnings Report

    Aug 7 22:19 ET

  • Lyell Immunopharma | 10-Q: Q1 2024 Earnings Report

    May 6 08:09 ET

  • Lyell Immunopharma | 10-K: FY2023 Annual Report

    Feb 28 22:28 ET

  • Lyell Immunopharma | 10-Q: Q3 2023 Earnings Report

    Nov 7, 2023 16:14 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data